5,7-dihydroxytryptamine has been researched along with Central Nervous System Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bervoets, K; Millan, MJ; Rivet, JM | 1 |
1 other study(ies) available for 5,7-dihydroxytryptamine and Central Nervous System Disease
Article | Year |
---|---|
5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat.
Topics: 5,7-Dihydroxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Biogenic Monoamines; Brain; Central Nervous System Diseases; Dose-Response Relationship, Drug; Injections, Intraventricular; Injections, Spinal; Injections, Subcutaneous; Male; Methoxydimethyltryptamines; Neurons; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Spinal Cord; Synapses; Tail | 1993 |